Scopio
Healthcare Software · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10 Hasharon, Tel Aviv Yafo, Tel Aviv, Is...Phone Number
+972 737330254Website
www.scopiolabs.comRevenue
$25.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
2
1
1
About Scopio
Scopio Labs is transforming cell morphology analysis, offering a suite of fully digital diagnostic applications and platforms that drastically enhance clinical workflows and enable faster, earlier, and more accurate detection and diagnosis of disease, expediting patients' access to life-saving treatments. Solving the tradeoff between field-of-view and resolution, Scopio enables labs to assess and analyze cell morphology at unprecedented scale and depth. The company's combination of high-resolution imaging and an AI-powered decision support system makes the diagnosis process more efficient and consistent across the continuum of care. Scopio Labs' FDA-cleared, CE-marked Full-Field Peripheral Blood Smear application and its ScopioVet veterinary application are in full commercial use across the U.S. and Europe.Explore more
Scopio Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scopio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Scopio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Scopio has new funding data
Click to see if Scopio had a recent Job posting/layoffs
Scopio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Scopio is spiking on competitors!
Earning: See what the market has to say on Scopio recently announced quarterly report
Check if Scopio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Scopio
Recommended Actions
Find VP level buyers at Scopio
Find 3 more new buyers
Company Profile Activity
Activity Insights
Scopio is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Scopio is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Scopio.
Scopio financials insights
Gather financial insights about Scopio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series B
$16M
2022
Series C
$50M
2025
Series D
$52M
Scopio Tech Stack
A closer look at the technologies used by Scopio
See more technologies
Most Recent Scoops
Hiring Plans
Scopio has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Open Position
Open Position
Funding
Funding
Scopio News & Media
Scopio Labs Achieves EU IVDR Certification for AI-Powered Full-Field Digital Morphology Platforms
PARSIPPANY, N.J., Feb. 25, 2026 /PRNewswire/ -- Scopio Labs today announced it has achieved IVDR certification from BSI, a major regulatory milestone that clears the path for its AI-driven digital morphology platforms in the European Union. The certification covers the company's QMS and...Scopio Labs extends Series D with additional $10 million | Ctech
The company’s round totals $52 million and will help advance its automated blood morphology technology.Scopio Labs Unveils First-of-Its-Kind AI-Powered Solution to Fully Automate Blood Morphology
Scopio's Complete Blood Morphology (CBM®) ushers in a new era of lab automation, analyzing 10x more cells than the current standard of care in blood cell morphology, addressing global laboratory staffing crisis and accelerating hematology workflows and efficiencies PARSIPPANY, N.J., July...Scopio Labs Receives Fourth FDA Clearance, Elevating Digital Morphology with Enhanced AI-Powered RBC and Platelet Capabilities
TEL AVIV, Israel, July 10, 2025 /PRNewswire/ -- Scopio Labs, a trailblazer in Full-Field Digital Cell Morphology, today announced another significant milestone: its fourth U.S. Food and Drug Administration (FDA) clearance (K243144). This latest clearance introduces powerful new Decision...
Read more news
Top Healthcare Software Companies
See more top companies
Frequently Asked Questions Regarding Scopio
Sign Up For FreeTo access detailed company insights
Scopio Labs is transforming cell morphology analysis, offering a suite of fully digital diagnostic applications and platforms that drastically enhance clinical workflows and enable faster, earlier, and more accurate detection and diagnosis of disease, expediting patients' access to life-saving treatments. Solving the tradeoff between field-of-view... Read More
